Anaflaksi ve Şoklu Hastaya Yaklaşım
Synopsis
Anaphylaxis is a sudden-onset, life-threatening systemic condition triggered by mediators released from mast cells and basophils, presenting within 5 to 30 minutes with cardiovascular collapse, respiratory distress, urticaria, and gastrointestinal symptoms. The most common causes include medications, foods, insect stings, physical factors, and latex. Diagnosis is primarily based on medical history and physical examination, with serum B-tryptase serving as a differential parameter. Early intervention is life-saving, and subcutaneous or intramuscular adrenaline (epinephrine) injection forms the cornerstone of treatment. In resistant cases, oxygen support, airway management, antihistamines (diphenhydramine), and glucocorticoids to reduce recurrence are utilized. Avoidance of allergens and desensitization are key preventive measures. Shock, defined as a state of cellular and tissue hypoxia resulting from impaired oxygen delivery, is categorized into four main types: distributive (septic, anaphylactic), cardiogenic, hypovolemic, and obstructive (such as pulmonary embolism). Patients in shock may present as hypotensive, normotensive, or hypertensive, and unmanaged cases can progress to multiple organ failure and death. Therefore, prompt diagnosis and targeted treatment are vital in both emergency conditions.
References
Yu JE, Lin RY. Epidemiology of Anaphylaxis. Clin Rev Allergy Immunol 2018; 54: 366
Campbell RL, Bashore CJ, Lee S, et al. Predictors of Repeated Epinephrine Administration in Emergency Department Anaphylaxis Patients. J Allergy Clin Immunol Pract 2015; 3: 576.
Kawano T, Scheuermeyer FX, Stenstrom R, et al. Epinephrine use in elderly patients with anaphylaxis: clinical results and cardiovascular complications. Resuscitation 2017; 112: 53.
Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Diseases / Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391.
Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013; 369: 1726.
De Backer D, Biston P, Devriendt J, et al. Dopamine and norepinephrine in shock treatment comparison. N Engl J Med 2010; 362: 779.